Jialiang Lin Selected Research

Palovarotene

1/2022	Palovarotene Can Attenuate Heterotopic Ossification Induced by Tendon Stem Cells by Downregulating the Synergistic Effects of Smad and NF-κB Signaling Pathway following Stimulation of the Inflammatory Microenvironment.
1/2022	Palovarotene inhibits the NF-κB signalling pathway to prevent heterotopic ossification.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jialiang Lin Research Topics

Disease

8	Intervertebral Disc Degeneration 01/2021 - 10/2018
5	Neoplasms (Cancer) 01/2022 - 10/2006
4	Inflammation (Inflammations) 01/2022 - 04/2019
3	Heterotopic Ossification (Ectopic Ossification) 01/2022 - 01/2022
2	Diabetes Complications 01/2022 - 01/2021
2	Spinal Cord Injuries (Spinal Cord Injury) 01/2021 - 01/2020
2	Breast Neoplasms (Breast Cancer) 01/2020 - 09/2019
1	Wounds and Injuries (Trauma) 01/2022
1	Osteoporosis 01/2021
1	Osteoarthritis 10/2020
1	Back Pain (Backache) 10/2020
1	Compression Fractures (Compression Fracture) 10/2020
1	Carcinoma (Carcinomatosis) 08/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2020
1	Low Back Pain (Lumbago) 01/2020
1	Weight Loss (Weight Reduction) 01/2019
1	Hypertension (High Blood Pressure) 01/2019
1	Parkinson Disease (Parkinson's Disease) 08/2013

Drug/Important Bio-Agent (IBA)

2	Interleukin-17 (Interleukin 17)IBA 01/2022 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2019
2	Pharmaceutical PreparationsIBA 01/2022 - 08/2020
2	PalovaroteneIBA 01/2022 - 01/2022
2	naringinIBA 01/2021 - 10/2018
2	Transferrin Receptors (Transferrin Receptor)IBA 01/2020 - 09/2019
1	Celecoxib (Celebrex)FDA Link 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	poly(lactide) (polylactic acid)IBA 01/2022
1	Smad Proteins (Mothers Against Decapentaplegic Homolog)IBA 01/2022
1	glycolic acid (glycolate)IBA 01/2022
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021
1	danggui siniIBA 01/2021
1	SirtuinsIBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	S-allylcysteine (allyl cysteine)IBA 10/2020
1	tert-ButylhydroperoxideIBA 10/2020
1	3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-oneIBA 01/2020
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2020
1	astragaloside AIBA 01/2020
1	PolymersIBA 09/2019
1	MicellesIBA 09/2019
1	Sirolimus (Rapamycin)FDA Link 09/2019
1	polyethylene glycol- distearoylphosphatidylethanolamineIBA 09/2019
1	ligustilideIBA 04/2019
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2019
1	DiureticsIBA 01/2019
1	Sirtuin 1IBA 01/2019
1	MelatoninIBA 01/2019
1	luteolin-7-glucosideIBA 01/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2014
1	DisulfidesIBA 10/2014
1	polyethylene glycol bis(succinimidyl succinate)IBA 10/2014
1	Ethylene Glycol (Monoethylene Glycol)IBA 10/2014
1	rasagiline (Azilect)FDA Link 08/2013
1	Prostaglandins AIBA 10/2006
1	Folic Acid (Vitamin M)FDA LinkGeneric 10/2006

Therapy/Procedure

4	Therapeutics 01/2020 - 01/2019
3	Drug Therapy (Chemotherapy) 01/2020 - 10/2006
1	Microspheres (Microsphere) 01/2022
1	Stem Cell Transplantation 01/2021
1	Kyphoplasty 10/2020
1	Lasers (Laser) 08/2020
1	Transdermal Patch 08/2013